ONO-5920

DRUG2 trials

Sponsors

Ono Pharmaceutical Co. Ltd

Conditions

Involutional Osteoporosis

Phase 3

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

CompletedNCT00212667

Ono Pharmaceutical Co. LtdInvolutional Osteoporosis

Start: 2002-08-31Target: 650Updated: 2012-10-11

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

CompletedNCT00212719

Ono Pharmaceutical Co. LtdInvolutional Osteoporosis

Start: 2003-05-31Target: 250Updated: 2012-10-11